IBM's Quantum AI for Precision Medicine Powered by GNQ Insilico

IBM Consulting, in partnership with GNQ Insilico, a California-based precision medicine TechBio company, is bringing the GNQ Suite to market — a quantum-enhanced causal AI platform for drug development, clinical trial design, and patient-specific treatment optimization — delivering defensible, mechanistic evidence that regulators, clinicians, and researchers can interrogate.

The platform combines:

• A curated, evidence-weighted biomedical causal knowledge graph
• Multi-layer causal reasoning, moving from predictive modeling (what is likely to happen) to biologically grounded mechanistic reasoning (how and why it happens) to counterfactual exploration (what if a different intervention were made)
• Executed through its Quantum Biological Reasoning Model (QBRM)

This architecture enables interventional and counterfactual reasoning across a large-scale causal graph. At the core is a living, multimodal Patient 360 model (BioAvatar) that integrates:

• EHR
• Multi-omics
• Imaging
• Digital pathology
• Streaming data

Insights are delivered through BioLens, providing explainable and traceable outputs for scientific and regulatory workflows.

Using this causal framework, GNQ enables:

• Mechanistic adverse event (AE) hypothesis generation with full causal evidence chains and source provenance
• Early and low-frequency safety signal detection, improving lead time vs. traditional case accumulation (timing varies by dataset and implementation)
• Individual patient risk stratification for toxicity prediction and contraindication profiling
• Resistance trajectory forecasting to support proactive therapy optimization and stratified care
• In silico trial design and cohort simulation, including eligibility matching to reduce protocol risk
• Explainable, audit-ready narratives for regulatory and clinical workflows (e.g., IND/NDA, PSUR/PBRER, DSMB reviews, tumor boards)

Built on AWS leveraging AWS HealthOmics, Amazon EKS, AWS Lambda, Amazon ECR, Amazon S3, Amazon DynamoDB, Amazon RDS (PostgreSQL), AWS Secrets Manager, AWS IAM, and Amazon Bedrock (on roadmap).